ScholarIQanswers from OpenAlex
University of St Andrews
InstitutionResearch output, impact & collaborations
University of St Andrews is a institution indexed in ScholarIQ from OpenAlex.
What is known about University of St Andrews?
ScholarIQrecord summary
University of St Andrews is a research organisation in St Andrews, GB. OpenAlex records 79,634 works and 4,827,326 citations for it. 7,978 researchers list it as their most recent affiliation.
How many works does University of St Andrews have?
ScholarIQindexed works
University of St Andrews has 79,634 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does University of St Andrews have?
ScholarIQcitation count
University of St Andrews has 4,827,326 citations in the OpenAlex counts ScholarIQ stores.
How many researchers are at University of St Andrews?
ScholarIQresearcher count
University of St Andrews has 7,978 researchers in the ScholarIQ index.
What is the average h-index at University of St Andrews?
ScholarIQavg h-index
University of St Andrews has an average h-index of 69.8 in OpenAlex.
What is the ROR of University of St Andrews?
ScholarIQror
The ROR for University of St Andrews is on the source record.
What is the OpenAlex record for University of St Andrews?
ScholarIQopenalex
The OpenAlex for University of St Andrews is on the source record.
Who are the most-cited researchers behind University of St Andrews?
ScholarIQtop researchers by citations
What are the most-cited papers on University of St Andrews?
ScholarIQmost cited works
The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups
METABRIC Group, Christina Curtis, Sohrab P. Shah, Suet‐Feung Chin, Gulisa Turashvili, Oscar M. Rueda, Mark Dunning, Doug Speed, Andy G. Lynch, Shamith Samarajiwa, Yinyin Yuan, Stefan Gräf, Gavin Ha, Gholamreza Haffari, Ali Bashashati, Roslin Russell, Steven McKinney, Anita Langerød, Andrew R. Green, Elena Provenzano, Gordon Wishart, Sarah E. Pinder, Peter H. Watson, Florian Markowetz, Leigh C. Murphy, Ian O. Ellis, Arnie Purushotham, Anne‐Lise Børresen‐Dale, James D. Brenton, Simon Tavaré, Carlos Caldas, Samuel Aparício
Roary: rapid large-scale prokaryote pan genome analysis
Andrew J. Page, Carla Cummins, Martin Hunt, Vanessa Wong, Sandra Reuter, Matthew T. G. Holden, María Fookes, Daniel Falush, Jacqueline A. Keane, Julian Parkhill
Using social and behavioural science to support COVID-19 pandemic response
Jay Joseph Van Bavel, Katherine Baicker, Paulo S. Boggio, Valerio Capraro, Aleksandra Cichocka, Mina Cikara, Molly J. Crockett, Alia J. Crum, Karen M. Douglas, James Druckman, John Drury, Oeindrila Dube, Naomi Ellemers, Eli J. Finkel, James H. Fowler, Michele J. Gelfand, Shihui Han, S. Alexander Haslam, Jolanda Jetten, Shinobu Kitayama, Dean Mobbs, Lucy E. Napper, Dominic J. Packer, Gordon Pennycook, Ellen Peters, Richard E. Petty, David G. Rand, Stephen Reicher, Simone Schnall, Azim Shariff, Linda J. Skitka, Sandra Susan Smith, Cass R. Sunstein, Nassim Tabri, Joshua A. Tucker, Sander van der Linden, Paul A. M. Van Lange, Kim A. Weeden, Michael J. A. Wohl, Jamil Zaki, Sean R. Zion, Robb Willer
Donanemab in Early Symptomatic Alzheimer Disease
John R. Sims, Jennifer A. Zimmer, Cynthia Evans, Ming‐Chi Lu, Paul Ardayfio, JonDavid Sparks, Alette M. Wessels, Sergey Shcherbinin, Hong Wang, Emel Serap Monkul Nery, Emily C. Collins, Paul R. Solomon, Stephen Salloway, Liana G. Apostolova, Oskar Hansson, Craig Ritchie, Dawn A. Brooks, Mark A. Mintun, Daniel Skovronsky, TRAILBLAZER-ALZ 2 Investigators, Rafael Abreu, Pinky Agarwal, Puja Aggarwal, Marc Agronin, Alison Allen, Dario Altamirano, Gustavo Alva, James Andersen, Allan Anderson, Donald D. Anderson, Jennifer Arnold, Takashi Asada, Yasuhiro Aso, Vikram Atit, Ricardo Ayala, Michael Badruddoja, Hanna Badzio-jagiello, Michal Bajaček, Dávid Barton, David G. Bear, Sabrina Benjamin, Richard Bergeron, Perminder Bhatia, Sandra E. Black, Allan Block, Mohammad Reza Bolouri, Wendy Bond, Jean Bouthillier, Sharon A. Brangman, Bruce J. Brew, Sarah Brisbin, Toby Brisken, Amy Brodtmann, Mark Brody, Jared R. Brosch, Celia Brown, Paul Brownstone, Sylwia Bukowczan, Jeffrey M. Burns, A Cabrera, Horace Capote, Ángel Carrasco, José Yépez, Eric Chavez, Howard Chertkow, Urszula Chyrchel-Paszkiewicz, Anthony Ciabarra, Edward Clemmons, Daniel M. Cohen, Robert M. Cohen, Ian J. Cohen, Mauricio Concha, Brian Costell, Denis Crimmins, Yvette Cruz-pagan, Adolfo Cueli, Robert Cupelo, Maciej Czarnecki, David Darby, P. L. J. Dautzenberg, Peter Paul De Deyn, Jose De La Gandara, Kenneth Deck, David DiBenedetto, Mark DiBuono, Eric Dinnerstein, Ahmet Dirican, Shanker Dixit, Jacek Dobryniewski, Ryan Drake, Peter Drysdale, Ranjan Duara, John P. Duffy, Aaron Ellenbogen, Victor Faradji, Marc Feinberg, Robert Feldman, Simon Fishman, Stephen Flitman, Concetta Forchetti
The PRECIS-2 tool: designing trials that are fit for purpose
Kirsty Loudon, Shaun Treweek, Frank Sullivan, Peter T. Donnan, Kevin E. Thorpe, Merrick Zwarenstein
How much of the research on University of St Andrews is open access?
ScholarIQopen access share
92%OPEN ACCESS